EMA Tightens Links With Academia To Boost Innovation And Regulatory Science

A new framework for interactions between the EMA and the academic community is expected to foster innovation in new drugs and evaluation methodologies, by keeping the agency in touch with cutting-edge research and giving academics the chance to benefit more from the expertise in the EU regulatory network.

Scientist conducting a laboratory experiment in a cancer research facility in the United States, 1951.
The EMA wants to build stronger links with academia to boost innovation and regulatory science

More from R&D

More from Pink Sheet